Similarly, in an early-phase human RA study, elevated levels of miR-5196 have been observed in RA patients prior to anti-TNF-α therapy and are reduced following treatment, suggesting a role as a predictive biomarker [124]. The gene discussed is TNF; the disease is rheumatoid arthritis.